Randomized Suicide Prevention Trial Using ASSIP and ACT in Suicide Attempters
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorArdakan University
About this trial
This is a randomized controlled trial that aims to compare the effectiveness of two psychological treatment approaches: the Attempted Suicide Short Intervention Program (ASSIP) and Acceptance and Commitment Therapy (ACT). The study seeks to determine which of these two methods is more effective in reducing suicidal ideation and mental pain in individuals who have recently attempted suicide.
In this study, 60 participants with a history of suicide attempts will be randomly assigned to three groups. One group will receive ASSIP in addition to treatment as usual (TAU), the second group will receive ACT alongside TAU, and the third group will be a control group receiving TAU only. The results will be assessed using the Beck Scale for Suicide Ideation (BSSI) and the Orbach \& Mikulincer Mental Pain Scale (OMMP) at three stages: pre-test, post-test, and follow-up.
The ultimate goal of this research is to provide valuable insights into the comparative effectiveness of ASSIP and ACT interventions for suicide attempters and to contribute to evidence-based suicide prevention strategies. The findings are expected to inform clinical practice and guide future research in this field.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Being 18 years of age or older
Having the ability to read and write
Providing informed consent to participate in the study
Having at least one suicide attempt in the past 4 months
Disqualifiers
Having a severe psychiatric or physical illness that interferes with the treatment process
Receiving concurrent structured psychological interventions (other than TAU) that may interfere with the study's treatment process.
Lack of informed consent to participate in the study
Substance abuse based on DSM-5 criteria
Trial design
Design model
Parallel
Treatments tested in this trial
Attempted Suicide Short Intervention Program (ASSIP)
BehavioralThis is a brief, structured, patient-centered therapy consisting of three to four face-to-face sessions. Each session typically lasts between 60 to 90 minutes. A fourth session may be added if clinically necessary.
Acceptance and Commitment Therapy (ACT)
BehavioralThis intervention uses the "ACT for Life" protocol, which is designed to maximize recovery after suicidal crises. It consists of three components delivered over three to six individual sessions. The average number of sessions is four to five, with each session lasting approximately 60 minutes.
Treatment as Usual (TAU)
Other interventionTreatment as usual (TAU) is not a structured intervention within this study. It may include standard outpatient or inpatient services, pharmacotherapy, or no structured treatment, depending on individual circumstances.
Treatment groups
60 Participants
are divided into 3 treatment groupsGroup A: ASSIP + TAUExperimental treatment 2 interventions
Group B: ACT + TAUExperimental treatment 2 interventions
Group C: Control Group (TAU only)Other 1 intervention
Trial outcomes
Primary outcomes
1
Mental Pain
This measure assesses the intensity of mental pain using the 44-item Orbach \& Mikulincer Mental Pain Scale (OMMP). The scale has nine subscales to measure various aspects of mental pain, including inevitability, lack of control, narcissism/worthlessness, emotional turmoil, numbness, alienation, confusion, social withdrawal, and emptiness (meaninglessness).
Time frame
pre-intervention, immediately following the intervention, and at 1-month follow-up2
Suicidal Ideation
This measure assesses suicidal thoughts, attitudes, and behaviors using the 19-item self-report Beck Scale for Suicide Ideation (BSSI). Each item is rated on a Likert scale from 0 to 2, with a total score ranging from 0 to 38. A score of 0-5 indicates no suicidal ideation, 6-19 suggests the presence of suicidal thoughts, and 20-38 signifies a high level of suicide ideation and planning.
Time frame
pre-intervention, immediately following the intervention, and at 1-month follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov